Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by porksnifferon May 13, 2021 9:38am
131 Views
Post# 33190567

RE:Halt ... just a shuffle

RE:Halt ... just a shuffle
MrMugsy wrote: Samira gets CEO position as well.
Goodman to Board as Chair.
Gale to Lead Director.

“I have worked side by side with Samira for 18 years where I have had the privilege of watching her develop into a seasoned, top brass executive. Knight is my baby, and as such, I would only entrust its stewardship to the best and brightest. As Executive Chairman and Knight’s largest shareholder, I will remain engaged and focused on non-operational areas where I can add the most value,” said Jonathan Ross Goodman




LMFAO....'just a shuffle'????   JRG basically resigned or more likely PUSHED out. The quote is nothing but fluff to calm the market. You just lost all these alleged 'bets' you claim others have made. The 3 posters you've been consistently bashing ended up being right. You are full of it loll and have a LOT of apologising to do. 
<< Previous
Bullboard Posts
Next >>